<?xml version="1.0" encoding="UTF-8"?>
<p id="P37">The mechanism of action and spectrum of activity of valacyclovir is identical to those of acyclovir. It is approved for the treatment of initial or recurrent episodes of genital herpes
 <sup>
  <xref ref-type="bibr" rid="R76">76</xref>
 </sup> and for the treatment of recurrent herpes labialis.
 <sup>
  <xref ref-type="bibr" rid="R4">4</xref>
 </sup> Treatment is most efficacious when initiated at the earliest onset of symptoms.
 <sup>
  <xref ref-type="bibr" rid="R4">4</xref>
 </sup> Suppressive therapy with valacyclovir is recommended to prevent recurrent genital herpes
 <sup>
  <xref ref-type="bibr" rid="R76">76</xref>
 </sup> and has the potential to reduce transmission to sexual partners.
 <sup>
  <xref ref-type="bibr" rid="R4">4</xref>
 </sup>
</p>
